{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:51:13Z","timestamp":1792291873734,"version":"4.4.0"},"reference-count":198,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2019,3,26]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Amino acids are essential components in various biochemical pathways. The deprivation of certain amino acids is an antimetabolite strategy for the treatment of amino acid-dependent cancers which exploits the compromised metabolism of malignant cells. Several studies have focused on the development and preclinical and clinical evaluation of amino acid degrading enzymes, namely L-asparaginase, L-methionine \u03b3-lyase, L-arginine deiminase, L-lysine \u03b1-oxidase. Further research into cancer cell metabolism may therefore define possible targets for controlling tumor growth.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective:<\/jats:title><jats:p>The purpose of this review was to summarize recent progress in the relationship between amino acids metabolism and cancer therapy, with a particular focus on Lasparagine, L-methionine, L-arginine and L-lysine degrading enzymes and their formulations, which have been successfully used in the treatment of several types of cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>We carried out a structured search among literature regarding to amino acid degrading enzymes. The main aspects of search were in vitro and in vivo studies, clinical trials concerning application of these enzymes in oncology.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Most published research are on the subject of L-asparaginase properties and it\u2019s use for cancer treatment. L-arginine deiminase has shown promising results in a phase II trial in advanced melanoma and hepatocellular carcinoma. Other enzymes, in particular Lmethionine \u03b3-lyase and L-lysine \u03b1-oxidase, were effective in vitro and in vivo.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>The findings of this review revealed that therapy based on amino acid depletion may have the potential application for cancer treatment but further clinical investigations are required to provide the efficacy and safety of these agents.<\/jats:p><\/jats:sec>","DOI":"10.2174\/0929867324666171006132729","type":"journal-article","created":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T11:43:23Z","timestamp":1507635803000},"page":"446-464","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Amino Acid Degrading Enzymes and their Application in Cancer Therapy"],"prefix":"10.2174","volume":"26","author":[{"given":"Vadim S.","family":"Pokrovsky","sequence":"first","affiliation":[{"name":"Blokhin Cancer Research Center, Moscow, Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga E.","family":"Chepikova","sequence":"additional","affiliation":[{"name":"Institute of Molecular Medicine, Sechenov First Moscow State Medical University, Moscow, Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis Zh.","family":"Davydov","sequence":"additional","affiliation":[{"name":"Blokhin Cancer Research Center, Moscow, Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey A.","family":"Zamyatnin Jr","sequence":"additional","affiliation":[{"name":"Institute of Molecular Medicine, Sechenov First Moscow State Medical University, Moscow, Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander N.","family":"Lukashev","sequence":"additional","affiliation":[{"name":"Institute of Molecular Medicine, Sechenov First Moscow State Medical University, Moscow, Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena V.","family":"Lukasheva","sequence":"additional","affiliation":[{"name":"People's Friendship University, Russia (RUDN University), Moscow, Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrc3038","volume":"11","author":"Koppenol W.H.","year":"2011","unstructured":"Koppenol WH, Bounds PL, Dang CV. Otto Warburg\u2019s contributions to current concepts of cancer metabolism.","journal-title":"Nat Rev Cancer"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"Warburg O.","year":"1956","unstructured":"Warburg O. On the origin of cancer cells.","journal-title":"Science"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2049-3002-1-5","volume":"1","author":"Macintyre A.N.","year":"2013","unstructured":"Macintyre AN, Rathmell JC. Activated lymphocytes as a metabolic model for carcinogenesis.","journal-title":"Cancer Metab"},{"key":"ref=4","first-page":"2423","volume":"32","author":"Avramis V.I.","year":"2012","unstructured":"Avramis VI. Asparaginases: Biochemical pharmacology and modes of drug resistance.","journal-title":"Anticancer Res"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/ng.890","volume":"43","author":"Locasale J.W.","year":"2011","unstructured":"Locasale JW, Grassian AR, Melman T, Lyssiotis CA, Mattaini KR, Bass AJ, Heffron G, Metallo CM, Muranen T, Sharfi H, Sasaki AT, Anastasiou D, Mullarky E, Vokes NI, Sasaki M, Beroukhim R, Stephanopoulos G, Ligon AH, Meyerson M, Richardson AL, Chin L, Wagner G, Asara JM, Brugge JS, Cantley LC, Vander Heiden MG. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis.","journal-title":"Nat Genet"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"e248","DOI":"10.1038\/cddis.2011.123","volume":"3","author":"Mu\u00f1oz-Pinedo C.","year":"2012","unstructured":"Mu\u00f1oz-Pinedo C, El Mjiyad N, Ricci JE. Cancer metabolism: Current perspectives and future directions.","journal-title":"Cell Death Dis"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/nm.3217","volume":"19","author":"T\u00f6njes M.","year":"2013","unstructured":"T\u00f6njes M, Barbus S, Park YJ, Wang W, Schlotter M, Lindroth AM, Pleier SV, Bai AHC, Karra D, Piro RM, Felsberg J, Addington A, Lemke D, Weibrecht I, Hovestadt V, Rolli CG, Campos B, Turcan S, Sturm D, Witt H, Chan TA, Herold-Mende C, Kemkemer R, K\u00f6nig R, Schmidt K, Hull WE, Pfister SM, Jugold M, Hutson SM, Plass C, Okun JG, Reifenberger G, Lichter P, Radlwimmer B. BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1.","journal-title":"Nat Med"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"E592","DOI":"10.1152\/ajpendo.90645.2008","volume":"296","author":"Avruch J.","year":"2009","unstructured":"Avruch J, Long X, Ortiz-Vega S, Rapley J, Papageorgiou A, Dai N. Amino acid regulation of TOR complex 1.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cell.2008.11.044","volume":"136","author":"Nicklin P.","year":"2009","unstructured":"Nicklin P, Bergman P, Zhang B, Triantafellow E, Wang H, Nyfeler B, Yang H, Hild M, Kung C, Wilson C, Myer VE, MacKeigan JP, Porter JA, Wang YK, Cantley LC, Finan PM, Murphy LO. Bidirectional transport of amino acids regulates mTOR and autophagy.","journal-title":"Cell"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1182\/blood-2013-03-493163","volume":"122","author":"Willems L.","year":"2013","unstructured":"Willems L, Jacque N, Jacquel A, Neveux N, Maciel TT, Lambert M, Schmitt A, Poulain L, Green AS, Uzunov M, Kosmider O, Radford-Weiss I, Moura IC, Auberger P, Ifrah N, Bardet V, Chapuis N, Lacombe C, Mayeux P, Tamburini J, Bouscary D. Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia.","journal-title":"Blood"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.18632\/oncotarget.2869","volume":"6","author":"Song P.","year":"2015","unstructured":"Song P, Ye L, Fan J, Li Y, Zeng X, Wang Z, Wang S, Zhang G, Yang P, Cao Z, Ju D. Asparaginase induces apoptosis and cytoprotective autophagy in chronic myeloid leukemia cells.","journal-title":"Oncotarget"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1111\/j.1582-4934.2012.01547.x","volume":"16","author":"Yu M.","year":"2012","unstructured":"Yu M, Henning R, Walker A, Kim G, Perroy A, Alessandro R, Virador V, Kohn EC. L-asparaginase inhibits invasive and angiogenic activity and induces autophagy in ovarian cancer.","journal-title":"J Cell Mol Med"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"33512","DOI":"10.18632\/oncotarget.9257","volume":"7","author":"Karpel-Massler G.","year":"2016","unstructured":"Karpel-Massler G, Ramani D, Shu C, Halatsch ME, Westhoff MA, Bruce JN, Canoll P, Siegelin MD. Metabolic reprogramming of glioblastoma cells by L-asparaginase sensitizes for apoptosis and","journal-title":"Oncotarget"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"62","DOI":"10.18097\/pbmc20176301062","volume":"63","author":"Pokrovskaya M.V.","year":"2017","unstructured":"Pokrovskaya MV, Zhdanov DD, Eldarov MA, Aleksandrova SS, Veselovskiy AV, Pokrovskiy VS, Grishin DV, Gladilina JA, Sokolov NN. [Suppression of telomerase activity leukemic cells by mutant forms of Rhodospirillum rubrum L-asparaginase].","journal-title":"Biomed Khim"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.bbrc.2017.08.078","volume":"492","author":"Zhdanov D.D.","year":"2017","unstructured":"Zhdanov DD, Pokrovsky VS, Pokrovskaya MV, Alexandrova SS, Eldarov MA, Grishin DV, Basharov MM, Gladilina YA, Podobed OV, Sokolov NN. targets tumor growth by a dual mechanism involving telomerase inhibition.","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=16","first-page":"137","volume":"3","author":"Kumar D.S.","year":"2012","unstructured":"Kumar DS, Sobha K. L-Asparaginase from Microbes: A Comprehensive Review.","journal-title":"Advances in Bioresearch"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"627","DOI":"10.18388\/abp.2006_3291","volume":"53","author":"Michalska K.","year":"2006","unstructured":"Michalska K, Jaskolski M. Structural aspects of L-asparaginases, their friends and relations.","journal-title":"Acta Biochim Pol"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"491","DOI":"10.18388\/abp.1997_4399","volume":"44","author":"Bonthron D.T.","year":"1997","unstructured":"Bonthron DT, Jask\u00f3lski M. Why a \u201cbenign\u201d mutation kills enzyme activity. Structure-based analysis of the A176V mutant of L-asparaginase I.","journal-title":"Acta Biochim Pol"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1107\/S0907444904032950","volume":"61","author":"Yao M.","year":"2005","unstructured":"Yao M, Yasutake Y, Morita H, Tanaka I. Structure of the type I L-asparaginase from the hyperthermophilic archaeon at 2.16 angstroms resolution.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1182\/blood-2010-07-298422","volume":"117","author":"Offman M.N.","year":"2011","unstructured":"Offman MN, Krol M, Patel N, Krishnan S, Liu J, Saha V, Bates PA. Rational engineering of L-asparaginase reveals importance of dual activity for cancer cell toxicity.","journal-title":"Blood"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"312","DOI":"10.18097\/pbmc20156103312","volume":"61","author":"Sokolov N.N.","year":"2015","unstructured":"Sokolov NN, Eldarov MA, Pokrovskaya MV, Aleksandrova SS, Abakumova OY, Podobed OV, Melik-Nubarov NS, Kudryashova EV, Grishin DV, Archakov AI. [Bacterial recombinant L-asparaginases: properties, structure and anti-proliferative activity].","journal-title":"Biomed Khim"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/BF02619582","volume":"20","author":"Ankel E.G.","year":"1984","unstructured":"Ankel EG, Zirneski J, Ring BJ, Holcenberg JS. Effect of asparaginase on cell membranes of sensitive and resistant mouse lymphoma cells.","journal-title":"In Vitro"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12013-011-9253-x","volume":"62","author":"Liu J.J.","year":"2012","unstructured":"Liu JJ, Dai XJ, Xu Y, Liu PQ, Zhang Y, Liu XD, Fang ZG, Lin DJ, Xiao RZ, Huang RW, Huang HQ. Inhibition of lymphoma cell proliferation by peroxisomal proliferator-activated receptor-\u03b3 ligands via Wnt signaling pathway.","journal-title":"Cell Biochem Biophys"},{"key":"ref=24","first-page":"2400","volume":"32","author":"Fidler I.J.","year":"1972","unstructured":"Fidler IJ, Montgomery PC. Effects of L-asparaginase on lymphocyte surface and blastogenesis.","journal-title":"Cancer Res"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1158\/1078-0432.CCR-10-1114","volume":"17","author":"Hervas-Stubbs S.","year":"2011","unstructured":"Hervas-Stubbs S, Perez-Gracia JL, Rouzaut A, Sanmamed MF, Le Bon A, Melero I. Direct effects of type I interferons on cells of the immune system.","journal-title":"Clin Cancer Res"},{"key":"ref=26","first-page":"2014","volume":"33","author":"Vadlamudi S.","year":"1973","unstructured":"Vadlamudi S, Krishna B, Reddy VV, Goldin A. Schedule-dependent therapeutic synergism for L-asparaginase and methotrexate in leukemic (L5178Y) mice.","journal-title":"Cancer Res"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4103\/0976-500X.184769","volume":"7","author":"Egler R.A.","year":"2016","unstructured":"Egler RA, Ahuja SP, Matloub Y. L-asparaginase in the treatment of patients with acute lymphoblastic leukemia.","journal-title":"J Pharmacol Pharmacother"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/annonc\/mdn542","volume":"20","author":"Jaccard A.","year":"2009","unstructured":"Jaccard A, Petit B, Girault S, Suarez F, Gressin R, Zini JM, Coiteux V, Larroche C, Devidas A, Thi\u00e9blemont C, Gaulard P, Marin B, Gachard N, Bordessoule D, Hermine O. L-asparaginase-based treatment of 15 western patients with extranodal NK\/T-cell lymphoma and leukemia and a review of the literature.","journal-title":"Ann Oncol"},{"key":"ref=29","first-page":"260","volume":"69","author":"Obama K.","year":"1999","unstructured":"Obama K, Tara M, Niina K. L-asparaginase induced complete remission in Epstein-Barr virus positive, multidrug resistant, cutaneous T-cell lymphoma.","journal-title":"Int J Hematol"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1080\/14737140.2017.1344100","volume":"17","author":"Pokrovsky V.S.","year":"2017","unstructured":"Pokrovsky VS, Vinnikov D. L-Asparaginase for newly diagnosed extra-nodal NK\/T-cell lymphoma: Systematic review and meta-analysis.","journal-title":"Expert Rev Anticancer Ther"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF02983387","volume":"78","author":"Yong W.","year":"2003","unstructured":"Yong W, Zheng W, Zhang Y, Zhu J, Wei Y, Zhu D, Li J. L-asparaginase-based regimen in the treatment of refractory midline nasal\/nasal-type T\/NK-cell lymphoma.","journal-title":"Int J Hematol"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"S219","DOI":"10.1016\/S0959-8049(12)71537-X","volume":"48","author":"Pokrovsky V.S.","year":"2012","unstructured":"Pokrovsky VS, Anisimova NY, Pokrovskaya MV, Aleksandrova SS, Sokolov NN. L-asparaginase-a promising new chemotherapeutic agent.","journal-title":"Eur J Cancer"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/onc.2009.358","volume":"29","author":"DeBerardinis R.J.","year":"2010","unstructured":"DeBerardinis RJ, Cheng T. Q\u2019s next: The diverse functions of glutamine in metabolism, cell biology and cancer.","journal-title":"Oncogene"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"19345","DOI":"10.1073\/pnas.0709747104","volume":"104","author":"DeBerardinis R.J.","year":"2007","unstructured":"DeBerardinis RJ, Mancuso A, Daikhin E, Nissim I, Yudkoff M, Wehrli S, Thompson CB. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.gde.2008.02.003","volume":"18","author":"Deberardinis R.J.","year":"2008","unstructured":"Deberardinis RJ, Sayed N, Ditsworth D, Thompson CB. Brick by brick: metabolism and tumor cell growth.","journal-title":"Curr Opin Genet Dev"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2165\/00003088-200544040-00003","volume":"44","author":"Avramis V.I.","year":"2005","unstructured":"Avramis VI, Panosyan EH. Pharmacokinetic\/pharmacodynamic relationships of asparaginase formulations: The past, the present and recommendations for the future.","journal-title":"Clin Pharmacokinet"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000087238","volume":"15","author":"Rotoli B.M.","year":"2005","unstructured":"Rotoli BM, Uggeri J, Dall\u2019Asta V, Visigalli R, Barilli A, Gatti R, Orlandini G, Gazzola GC, Bussolati O. Inhibition of glutamine synthetase triggers apoptosis in asparaginase-resistant cells.","journal-title":"Cell Physiol Biochem"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00280-007-0421-z","volume":"60","author":"Tardito S.","year":"2007","unstructured":"Tardito S, Uggeri J, Bozzetti C, Bianchi MG, Rotoli BM, Franchi-Gazzola R, Gazzola GC, Gatti R, Bussolati O. The inhibition of glutamine synthetase sensitizes human sarcoma cells to L-asparaginase.","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1038\/onc.2016.364","volume":"36","author":"Cacace A.","year":"2017","unstructured":"Cacace A, Sboarina M, Vazeille T, Sonveaux P. Glutamine activates STAT3 to control cancer cell proliferation independently of glutamine metabolism.","journal-title":"Oncogene"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"31222","DOI":"10.1074\/jbc.M604511200","volume":"281","author":"Reinert R.B.","year":"2006","unstructured":"Reinert RB, Oberle LM, Wek SA, Bunpo P, Wang XP, Mileva I, Goodwin LO, Aldrich CJ, Durden DL, McNurlan MA, Wek RC, Anthony TG. Role of glutamine depletion in directing tissue-specific nutrient stress responses to L-asparaginase.","journal-title":"J Biol Chem"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1152\/ajplegacy.1971.221.6.1785","volume":"221","author":"Woods J.S.","year":"1971","unstructured":"Woods JS, Handschumacher RE. Hepatic homeostasis of plasma L-asparagine.","journal-title":"Am J Physiol"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0378-4274(86)90113-X","volume":"32","author":"Villa P.","year":"1986","unstructured":"Villa P, Corada M, Bartosek I. L-asparaginase effects on inhibition of protein synthesis and lowering of the glutamine content in cultured rat hepatocytes.","journal-title":"Toxicol Lett"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1365-2362.1988.tb01049.x","volume":"18","author":"Ollenschl\u00e4ger G.","year":"1988","unstructured":"Ollenschl\u00e4ger G, Roth E, Linkesch W, Jansen S, Simmel A, M\u00f6dder B. Asparaginase-induced derangements of glutamine metabolism: the pathogenetic basis for some drug-related side-effects.","journal-title":"Eur J Clin Invest"},{"key":"ref=44","first-page":"273","volume":"48","author":"Bendich A.","year":"1982","unstructured":"Bendich A, Kafkewitz D, Abuchowski A, Davis FF. Immunological effects of native and polyethylene glycol-modified asparaginases from and in normal and tumour-bearing mice.","journal-title":"Clin Exp Immunol"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ijc.2910300314","volume":"30","author":"Distasio J.A.","year":"1982","unstructured":"Distasio JA, Salazar AM, Nadji M, Durden DL. Glutaminase-free asparaginase from vibrio succinogenes: An antilymphoma enzyme lacking hepatotoxicity.","journal-title":"Int J Cancer"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/978-3-642-99984-0_40","volume":"33","author":"Storti E.","year":"1970","unstructured":"Storti E, Quaglino D. Dysmetabolic and neurological complications in leukemia patients treated with L-asparaginase.","journal-title":"Recent Results Cancer Res"},{"key":"ref=47","first-page":"175","volume":"1","author":"Roberts J.","year":"1976","unstructured":"Roberts J, Schmid FA, Old LJ, Stockert E. A comparative study of the antitumor effectiveness of and","journal-title":"Cancer Biochem Biophys"},{"key":"ref=48","first-page":"4546","volume":"40","author":"Warrell R.P.","year":"1980","unstructured":"Warrell RP, Chou TC, Gordon C, Tan C, Roberts J, Sternberg SS, Philips FS, Young CW. Phase I evaluation of succinylated Acinetobacter glutaminase-asparaginase in adults.","journal-title":"Cancer Res"},{"key":"ref=49","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/pbc.21022","volume":"49","author":"Steiner M.","year":"2007","unstructured":"Steiner M, Attarbaschi A, Kastner U, Dworzak M, Haas OA, Gadner H, Mann G. Distinct fluctuations of ammonia levels during asparaginase therapy for childhood acute leukemia.","journal-title":"Pediatr Blood Cancer"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s12185-009-0419-x","volume":"90","author":"Watanabe S.","year":"2009","unstructured":"Watanabe S, Miyake K, Ogawa C, Matsumoto H, Yoshida K, Hirabayashi S, Hasegawa D, Inoue T, Kizu J, Machida R, Ohara A, Hosoya R, Manabe A. The production of ammonia predicts L-asparaginase biological activity in children with acute lymphoblastic leukemia.","journal-title":"Int J Hematol"},{"key":"ref=51","first-page":"1602","volume":"43","author":"Durden D.L.","year":"1983","unstructured":"Durden DL, Salazar AM, Distasio JA. Kinetic analysis of hepatotoxicity associated with antineoplastic asparaginases.","journal-title":"Cancer Res"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1182\/blood.V99.8.2734","volume":"99","author":"Duval M.","year":"2002","unstructured":"Duval M, Suciu S, Ferster A, Rialland X, Nelken B, Lutz P, Benoit Y, Robert A, Manel AM, Vilmer E, Otten J, Philippe N. Comparison of -asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: Results of a randomized European Organisation for Research and Treatment of Cancer-Children\u2019s Leukemia Group phase 3 trial.","journal-title":"Blood"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/mpo.2950180612","volume":"18","author":"Eden O.B.","year":"1990","unstructured":"Eden OB, Shaw MP, Lilleyman JS, Richards S. Non-randomised study comparing toxicity of Escherichia coli and Erwinia asparaginase in children with leukaemia.","journal-title":"Med Pediatr Oncol"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/01.mbc.0000214709.11492.ec","volume":"17","author":"Appel I.M.","year":"2006","unstructured":"Appel IM, Hop WC, Pieters R. Changes in hypercoagulability by asparaginase: A randomized study between two asparaginases.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S0021-9258(19)45610-X","volume":"247","author":"Howard J.B.","year":"1972","unstructured":"Howard JB, Carpenter FH. L-asparaginase from . Substrate specificity and enzymatic properties.","journal-title":"J Biol Chem"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1200\/JCO.1993.11.9.1780","volume":"11","author":"Asselin B.L.","year":"1993","unstructured":"Asselin BL, Whitin JC, Coppola DJ, Rupp IP, Sallan SE, Cohen HJ. Comparative pharmacokinetic studies of three asparaginase preparations.","journal-title":"J Clin Oncol"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.bbrc.2008.10.118","volume":"377","author":"Cappelletti D.","year":"2008","unstructured":"Cappelletti D, Chiarelli LR, Pasquetto MV, Stivala S, Valentini G, Scotti C. Helicobacter pyloril-asparaginase: A promising chemotherapeutic agent.","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=58","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s12033-014-9819-0","volume":"57","author":"Pokrovskaya M.V.","year":"2015","unstructured":"Pokrovskaya MV, Aleksandrova SS, Pokrovsky VS, Veselovsky AV, Grishin DV, Abakumova OY, Podobed OV, Mishin AA, Zhdanov DD, Sokolov NN. Identification of functional regions in the L-asparaginase by site-directed mutagenesis.","journal-title":"Mol Biotechnol"},{"key":"ref=59","first-page":"123","volume":"6","author":"Pokrovskaya M.V.","year":"2012","unstructured":"Pokrovskaya MV, Pokrovskiy VS, Aleksandrova SS, Anisimova NY, Andrianov RM, Treschalina EM, Ponomarev GV, Sokolov NN. Recombinant intracellular Rhodospirillum rubrum L-asparaginase with low L-glutaminase activity and antiproliferative effect. Biochemistry (Moscow).","journal-title":"Supplement Series B: Biomedical Chemistry"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1110\/ps.9.10.2009","volume":"9","author":"Derst C.","year":"2000","unstructured":"Derst C, Henseling J, R\u00f6hm KH. Engineering the substrate specificity of asparaginase. II. Selective reduction of glutaminase activity by amino acid replacements at position 248.","journal-title":"Protein Sci"},{"key":"ref=61","first-page":"175","volume":"7","author":"Abuchowski A.","year":"1984","unstructured":"Abuchowski A, Kazo GM, Verhoest CR, Van Es T, Kafkewitz D, Nucci ML, Viau AT, Davis FF. Cancer therapy with chemically modified enzymes. I. Antitumor properties of polyethylene glycol-asparaginase conjugates.","journal-title":"Cancer Biochem Biophys"},{"key":"ref=62","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1159\/000230429","volume":"40","author":"Khan A.","year":"1971","unstructured":"Khan A, Hill JM. Atopic hypersensitivity to L-asparaginase. Resistance to immunosuppression.","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"ref=63","first-page":"241","volume":"1","author":"Avramis V.I.","year":"2006","unstructured":"Avramis VI, Tiwari PN. Asparaginase (native ASNase or pegylated ASNase) in the treatment of acute lymphoblastic leukemia.","journal-title":"Int J Nanomedicine"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/(SICI)1096-911X(200003)34:3<200::AID-MPO7>3.0.CO;2-T","volume":"34","author":"Alvarez O.A.","year":"2000","unstructured":"Alvarez OA, Zimmerman G. Pegaspargase-induced pancreatitis.","journal-title":"Med Pediatr Oncol"},{"key":"ref=65","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1134\/S0003683817020119","volume":"53","author":"Melik-Nubarov N.","year":"2017","unstructured":"Melik-Nubarov N, Grozdova I, Lomakina GY, Pokrovskaya M, Pokrovski V, Aleksandrova S, Aba-kumova OY, Podobed O, Grishin D, Sokolov N. PEGylated recombinant L-asparaginase from : Production, properties, and potential applications.","journal-title":"Appl Biochem Microbiol"},{"key":"ref=66","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s002800050497","volume":"38","author":"Gaspar M.M.","year":"1996","unstructured":"Gaspar MM, Perez-Soler R, Cruz ME. Biological characterization of L-asparaginase liposomal formulations.","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref=67","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1470-8744.1997.tb01332.x","volume":"26","author":"Jean-Fran\u00e7ois J.","year":"1997","unstructured":"Jean-Fran\u00e7ois J, D\u2019Urso EM, Fortier G. Immobilization of L-asparaginase into a biocompatible poly(ethylene glycol)-albumin hydrogel: Evaluation of performance","journal-title":"Biotechnol Appl Biochem"},{"key":"ref=68","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0168-3659(97)00196-X","volume":"52","author":"Gasper M.M.","year":"1998","unstructured":"Gasper MM, Blanco D, Cruz ME, Alonso MJ. Formulation of L-asparaginase-loaded poly(lactide-co-glycolide) nanoparticles: influence of polymer properties on enzyme loading, activity and release.","journal-title":"J Control Release"},{"key":"ref=69","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3109\/10731199609118882","volume":"24","author":"Qian G.","year":"1996","unstructured":"Qian G, Zhou J, Ma J, Wang D, He B. The chemical modification of L-asparaginase by N,O-carboxymethyl chitosan.","journal-title":"Artif Cells Blood Substit Immobil Biotechnol"},{"key":"ref=70","first-page":"4068","volume":"42","author":"Uren J.R.","year":"1982","unstructured":"Uren JR, Hargis BJ, Beardsley P. Immunological and pharmacological characterization of poly-DL-alanyl-modified Erwinia carotovora L-asparaginase.","journal-title":"Cancer Res"},{"key":"ref=71","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/BF00685082","volume":"34","author":"Jorge J.C.","year":"1994","unstructured":"Jorge JC, Perez-Soler R, Morais JG, Cruz ME. Liposomal palmitoyl-L-asparaginase: Characterization and biological activity.","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1042\/BA20090229","volume":"55","author":"Leal-Ega\u00f1a A.","year":"2010","unstructured":"Leal-Ega\u00f1a A, Scheibel T. Silk-based materials for biomedical applications.","journal-title":"Biotechnol Appl Biochem"},{"key":"ref=73","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/mabi.201000071","volume":"10","author":"Spiess K.","year":"2010","unstructured":"Spiess K, Lammel A, Scheibel T. Recombinant spider silk proteins for applications in biomaterials.","journal-title":"Macromol Biosci"},{"key":"ref=74","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jbiotec.2005.06.027","volume":"120","author":"Zhang Y.Q.","year":"2005","unstructured":"Zhang YQ, Zhou WL, Shen WD, Chen YH, Zha XM, Shirai K, Kiguchi K. Synthesis, characterization and immunogenicity of silk fibroin-L-asparaginase bioconjugates.","journal-title":"J Biotechnol"},{"key":"ref=75","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jconrel.2009.06.027","volume":"139","author":"Kwon Y.M.","year":"2009","unstructured":"Kwon YM, Chung HS, Moon C, Yockman J, Park YJ, Gitlin SD, David AE, Yang VC. L-Asparaginase encapsulated intact erythrocytes for treatment of acute lymphoblastic leukemia (ALL).","journal-title":"J Control Release"},{"key":"ref=76","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1042\/bj3020921","volume":"302","author":"Moola Z.B.","year":"1994","unstructured":"Moola ZB, Scawen MD, Atkinson T, Nicholls DJ. Erwinia chrysanthemi L-asparaginase: epitope mapping and production of antigenically modified enzymes.","journal-title":"Biochem J"},{"key":"ref=77","first-page":"256","volume":"33","author":"Goldberg A.I.","year":"1973","unstructured":"Goldberg AI, Cooney DA, Glynn JP, Homan ER, Gaston MR, Milman HA. The effects of immunization to L-asparaginase on antitumor and enzymatic activity.","journal-title":"Cancer Res"},{"key":"ref=78","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/pbc.22225","volume":"54","author":"Vrooman L.M.","year":"2010","unstructured":"Vrooman LM, Supko JG, Neuberg DS, Asselin BL, Athale UH, Clavell L, Kelly KM, Laverdi\u00e8re C, Michon B, Schorin M, Cohen HJ, Sallan SE, Silverman LB. Erwinia asparaginase after allergy to asparaginase in children with acute lymphoblastic leukemia.","journal-title":"Pediatr Blood Cancer"},{"key":"ref=79","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10238-008-0026-9","volume":"9","author":"Zalewska-Szewczyk B.","year":"2009","unstructured":"Zalewska-Szewczyk B, Gach A, Wyka K, Bodalski J, M\u0142ynarski W. The cross-reactivity of anti-asparaginase antibodies against different L-asparaginase preparations.","journal-title":"Clin Exp Med"},{"key":"ref=80","doi-asserted-by":"crossref","first-page":"6929","DOI":"10.1016\/S0021-9258(17)32924-1","volume":"251","author":"Distasio J.A.","year":"1976","unstructured":"Distasio JA, Niederman RA, Kafkewitz D, Goodman D. Purification and characterization of L-asparaginase with anti-lymphoma activity from Vibrio succinogenes.","journal-title":"J Biol Chem"},{"key":"ref=81","first-page":"482","volume":"54","author":"Gladilina Iu A.","year":"2008","unstructured":"Gladilina Iu A, Sokolov NN, Krasotkina Iu V. [Cloning, expression and purification of Helicobater pylori L-asparaginase].","journal-title":"Biomed Khim"},{"key":"ref=82","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s12033-016-9950-1","volume":"58","author":"Sannikova E.P.","year":"2016","unstructured":"Sannikova EP, Bulushova NV, Cheperegin SE, Gubaydullin II, Chestukhina GG, Ryabichenko VV, Zalunin IA, Kotlova EK, Konstantinova GE, Kubasova TS, Shtil AA, Pokrovsky VS, Yarotsky SV, Efremov BD, Kozlov DG. the modified heparin-binding L-asparaginase of wolinella succinogenes.","journal-title":"Mol Biotechnol"},{"key":"ref=83","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10517-011-1493-7","volume":"152","author":"Sidoruk K.V.","year":"2011","unstructured":"Sidoruk KV, Pokrovsky VS, Borisova AA, Omeljanuk NM, Aleksandrova SS, Pokrovskaya MV, Gladilina JA, Bogush VG, Sokolov NN. Creation of a producent, optimization of expression, and purification of recombinant L-asparaginase.","journal-title":"Bull Exp Biol Med"},{"key":"ref=84","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12885-016-2125-4","volume":"16","author":"Pokrovsky V.S.","year":"2016","unstructured":"Pokrovsky VS, Kazanov MD, Dyakov IN, Pokrovskaya MV, Aleksandrova SS. Comparative immunogenicity and structural analysis of epitopes of different bacterial L-asparaginases.","journal-title":"BMC Cancer"},{"key":"ref=85","first-page":"100","author":"D\u2019Iakov I.N.","year":"2014","unstructured":"D\u2019Iakov IN, Pokrovskii VS, Sannikova EP, Bulusho-va NV, Pokrovskaia MV, Aleksandrova SS. [Cross-immunogenicity of various bacterial L-asparaginases].","journal-title":"Zh Mikrobiol Epidemiol Immunobiol"},{"key":"ref=86","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.pep.2011.12.005","volume":"82","author":"Pokrovskaya M.V.","year":"2012","unstructured":"Pokrovskaya MV, Aleksandrova SS, Pokrovsky VS, Omeljanjuk NM, Borisova AA, Anisimova NY, Sokolov NN. Cloning, expression and characterization of the recombinant Yersinia pseudotuberculosis L-asparaginase.","journal-title":"Protein Expr Purif"},{"key":"ref=87","first-page":"198","volume":"12","author":"Bach S.J.","year":"1947","unstructured":"Bach SJ, Lasnitzki I. Some aspects of the role of arginine and arginase in mouse carcinoma 63.","journal-title":"Enzymologia"},{"key":"ref=88","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1158\/0008-5472.CAN-06-1945","volume":"67","author":"Cheng P.N.","year":"2007","unstructured":"Cheng PN, Lam TL, Lam WM, Tsui SM, Cheng AW, Lo WH, Leung YC. Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the and proliferation of human hepatocellular carcinoma through arginine depletion.","journal-title":"Cancer Res"},{"key":"ref=89","first-page":"261","volume":"7","author":"Savoca K.V.","year":"1984","unstructured":"Savoca KV, Davis FF, van Es T, McCoy JR, Palczuk NC. Cancer therapy with chemically modified enzymes. II. The therapeutic effectiveness of arginase, and arginase modified by the covalent attachment of polyethylene glycol, on the taper liver tumor and the L5178Y murine leukemia.","journal-title":"Cancer Biochem Biophys"},{"key":"ref=90","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1182\/blood-2009-12-258822","volume":"115","author":"Hernandez C.P.","year":"2010","unstructured":"Hernandez CP, Morrow K, Lopez-Barcons LA, Zabaleta J, Sierra R, Velasco C, Cole J, Rodriguez PC. Pegylated arginase I: A potential therapeutic approach in T-ALL.","journal-title":"Blood"},{"key":"ref=91","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1756-8722-5-17","volume":"5","author":"Hsueh E.C.","year":"2012","unstructured":"Hsueh EC, Knebel SM, Lo WH, Leung YC, Cheng PN, Hsueh CT. Deprivation of arginine by recombinant human arginase in prostate cancer cells.","journal-title":"J Hematol Oncol"},{"key":"ref=92","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s10637-014-0200-8","volume":"33","author":"Yau T.","year":"2015","unstructured":"Yau T, Cheng PN, Chan P, Chen L, Yuen J, Pang R, Fan ST, Wheatley DN, Poon RT. Preliminary efficacy, safety, pharmacokinetics, pharmacodynamics and quality of life study of pegylated recombinant human arginase 1 in patients with advanced hepatocellular carcinoma.","journal-title":"Invest New Drugs"},{"key":"ref=93","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1016\/S0021-9258(19)41341-0","volume":"250","author":"Shibatani T.","year":"1975","unstructured":"Shibatani T, Kakimoto T, Chibata I. Crystallization and properties of L-arginine deiminase of Pseudomonas putida.","journal-title":"J Biol Chem"},{"key":"ref=94","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/ijc.2910510213","volume":"51","author":"Takaku H.","year":"1992","unstructured":"Takaku H, Takase M, Abe S, Hayashi H, Miyazaki K. anti-tumor activity of arginine deiminase purified from","journal-title":"Int J Cancer"},{"key":"ref=95","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/sj.bjc.6601181","volume":"89","author":"Park I.S.","year":"2003","unstructured":"Park IS, Kang SW, Shin YJ, Chae KY, Park MO, Kim MY, Wheatley DN, Min BH. Arginine deiminase: a potential inhibitor of angiogenesis and tumour growth.","journal-title":"Br J Cancer"},{"key":"ref=96","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00284-009-9376-0","volume":"58","author":"Ni Y.","year":"2009","unstructured":"Ni Y, Li Z, Sun Z, Zheng P, Liu Y, Zhu L, Schwaneberg U. Expression of arginine deiminase from CGMCC2039 in and its anti-tumor activity.","journal-title":"Curr Microbiol"},{"key":"ref=97","first-page":"5443","volume":"62","author":"Ensor C.M.","year":"2002","unstructured":"Ensor CM, Holtsberg FW, Bomalaski JS, Clark MA. Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas and","journal-title":"Cancer Res"},{"key":"ref=98","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/sj.leu.2401763","volume":"14","author":"Gong H.","year":"2000","unstructured":"Gong H, Z\u00f6lzer F, von Recklinghausen G, Havers W, Schweigerer L. Arginine deiminase inhibits proliferation of human leukemia cells more potently than asparaginase by inducing cell cycle arrest and apoptosis.","journal-title":"Leukemia"},{"key":"ref=99","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10637-012-9862-2","volume":"31","author":"Ott P.A.","year":"2013","unstructured":"Ott PA, Carvajal RD, Pandit-Taskar N, Jungbluth AA, Hoffman EW, Wu BW, Bomalaski JS, Venhaus R, Pan L, Old LJ, Pavlick AC, Wolchok JD. Phase I\/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma.","journal-title":"Invest New Drugs"},{"key":"ref=100","doi-asserted-by":"crossref","first-page":"e342","DOI":"10.1038\/cddis.2012.83","volume":"3","author":"Delage B.","year":"2012","unstructured":"Delage B, Luong P, Maharaj L, O\u2019Riain C, Syed N, Crook T, Hatzimichael E, Papoudou-Bai A, Mitchell TJ, Whittaker SJ, Cerio R, Gribben J, Lemoine N, Bomalaski J, Li CF, Joel S, Fitzgibbon J, Chen LT, Szlosarek PW. Promoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treatment, autophagy and caspase-dependent apoptosis.","journal-title":"Cell Death Dis"},{"key":"ref=101","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1158\/1078-0432.CCR-14-2610","volume":"21","author":"Tomlinson B.K.","year":"2015","unstructured":"Tomlinson BK, Thomson JA, Bomalaski JS, Diaz M, Akande T, Mahaffey N, Li T, Dutia MP, Kelly K, Gong IY, Semrad T, Gandara DR, Pan CX, Lara PN. Jr Phase I trial of arginine deprivation therapy with ADI-PEG 20 plus docetaxel in patients with advanced ma-lignant solid tumors.","journal-title":"Clin Cancer Res"},{"key":"ref=102","doi-asserted-by":"crossref","first-page":"7660","DOI":"10.1200\/JCO.2005.02.0933","volume":"23","author":"Ascierto P.A.","year":"2005","unstructured":"Ascierto PA, Scala S, Castello G, Daponte A, Simeone E, Ottaiano A, Beneduce G, De Rosa V, Izzo F, Melucci MT, Ensor CM, Prestayko AW, Holtsberg FW, Bomalaski JS, Clark MA, Savaraj N, Feun LG, Logan TF. Pegylated arginine deiminase treatment of patients with metastatic melanoma: Results from phase I and II studies.","journal-title":"J Clin Oncol"},{"key":"ref=103","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1200\/JCO.2009.26.7765","volume":"28","author":"Glazer E.S.","year":"2010","unstructured":"Glazer ES, Piccirillo M, Albino V, Di Giacomo R, Palaia R, Mastro AA, Beneduce G, Castello G, De Rosa V, Petrillo A, Ascierto PA, Curley SA, Izzo F. Phase II study of pegylated arginine deiminase for nonresectable and metastatic hepatocellular carcinoma.","journal-title":"J Clin Oncol"},{"key":"ref=104","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1200\/JCO.2004.11.120","volume":"22","author":"Izzo F.","year":"2004","unstructured":"Izzo F, Marra P, Beneduce G, Castello G, Vallone P, De Rosa V, Cremona F, Ensor CM, Holtsberg FW, Bomalaski JS, Clark MA, Ng C, Curley SA. Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: Results from phase I\/II studies.","journal-title":"J Clin Oncol"},{"key":"ref=105","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/sj.bjc.6605856","volume":"103","author":"Yang T.S.","year":"2010","unstructured":"Yang TS, Lu SN, Chao Y, Sheen IS, Lin CC, Wang TE, Chen SC, Wang JH, Liao LY, Thomson JA, Wang-Peng J, Chen PJ, Chen LT. A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients.","journal-title":"Br J Cancer"},{"key":"ref=106","author":"","year":"","unstructured":"."},{"key":"ref=107","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/bjc.2012.106","volume":"106","author":"Feun L.G.","year":"2012","unstructured":"Feun LG, Marini A, Walker G, Elgart G, Moffat F, Rodgers SE, Wu CJ, You M, Wangpaichitr M, Kuo MT, Sisson W, Jungbluth AA, Bomalaski J, Savaraj N. Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase.","journal-title":"Br J Cancer"},{"key":"ref=108","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/bjc.2011.524","volume":"106","author":"Kelly M.P.","year":"2012","unstructured":"Kelly MP, Jungbluth AA, Wu BW, Bomalaski J, Old LJ, Ritter G. Arginine deiminase PEG20 inhibits growth of small cell lung cancers lacking expression of argininosuccinate synthetase.","journal-title":"Br J Cancer"},{"key":"ref=109","first-page":"1495","volume":"25","author":"Manca A.","year":"2011","unstructured":"Manca A, Sini MC, Izzo F, Ascierto PA, Tatangelo F, Botti G, Gentilcore G, Capone M, Mozzillo N, Rozzo C, Cossu A, Tanda F, Palmieri G. Induction of arginosuccinate synthetase (ASS) expression affects the antiproliferative activity of arginine deiminase (ADI) in melanoma cells.","journal-title":"Oncol Rep"},{"key":"ref=110","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1200\/JCO.2012.42.1784","volume":"31","author":"Szlosarek P.W.","year":"2013","unstructured":"Szlosarek PW, Luong P, Phillips MM, Baccarini M, Stephen E, Szyszko T, Sheaff MT, Avril N. Metabolic response to pegylated arginine deiminase in mesothelioma with promoter methylation of argininosuccinate synthetase.","journal-title":"J Clin Oncol"},{"key":"ref=111","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/jgh.12043","volume":"28","author":"Wu L.","year":"2013","unstructured":"Wu L, Li L, Meng S, Qi R, Mao Z, Lin M. Expression of argininosuccinate synthetase in patients with hepatocellular carcinoma.","journal-title":"J Gastroenterol Hepatol"},{"key":"ref=112","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1002\/ijc.23723","volume":"123","author":"Bowles T.L.","year":"2008","unstructured":"Bowles TL, Kim R, Galante J, Parsons CM, Virudachalam S, Kung HJ, Bold RJ. Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase","journal-title":"Int J Cancer"},{"key":"ref=113","first-page":"1373","volume":"18","author":"Kim J.H.","year":"2007","unstructured":"Kim JH, Kim JH, Yu YS, Kim DH, Min BH, Kim KW. Anti-tumor activity of arginine deiminase arginine deprivation in retinoblastoma.","journal-title":"Oncol Rep"},{"key":"ref=114","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1158\/0008-5472.CAN-08-3157","volume":"69","author":"Kim R.H.","year":"2009","unstructured":"Kim RH, Coates JM, Bowles TL, McNerney GP, Sutcliffe J, Jung JU, Gandour-Edwards R, Chuang FY, Bold RJ, Kung HJ. Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis.","journal-title":"Cancer Res"},{"key":"ref=115","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00008390-199209000-00007","volume":"2","author":"Sugimura K.","year":"1992","unstructured":"Sugimura K, Ohno T, Kusuyama T, Azuma I. High sensitivity of human melanoma cell lines to the growth inhibitory activity of mycoplasmal arginine deiminase","journal-title":"Melanoma Res"},{"key":"ref=116","doi-asserted-by":"crossref","first-page":"7126","DOI":"10.1158\/1078-0432.CCR-06-1101","volume":"12","author":"Szlosarek P.W.","year":"2006","unstructured":"Szlosarek PW, Klabatsa A, Pallaska A, Sheaff M, Smith P, Crook T, Grimshaw MJ, Steele JP, Rudd RM, Balkwill FR, Fennell DA. In vivo loss of expression of argininosuccinate synthetase in malignant pleural mesothelioma is a biomarker for susceptibility to arginine depletion.","journal-title":"Clin Cancer Res"},{"key":"ref=117","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/ijc.22322","volume":"120","author":"Yoon C.Y.","year":"2007","unstructured":"Yoon CY, Shim YJ, Kim EH, Lee JH, Won NH, Kim JH, Park IS, Yoon DK, Min BH. Renal cell carcinoma does not express argininosuccinate synthetase and is highly sensitive to arginine deprivation arginine deiminase.","journal-title":"Int J Cancer"},{"key":"ref=118","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/jamaoncol.2016.3049","volume":"3","author":"Szlosarek P.W.","year":"2017","unstructured":"Szlosarek PW, Steele JP, Nolan L, Gilligan D, Taylor P, Spicer J, Lind M, Mitra S, Shamash J, Phillips MM, Luong P, Payne S, Hillman P, Ellis S, Szyszko T, Dancey G, Butcher L, Beck S, Avril NE, Thomson J, Johnston A, Tomsa M, Lawrence C, Schmid P, Crook T, Wu BW, Bomalaski JS, Lemoine N, Sheaff MT, Rudd RM, Fennell D, Hackshaw A. Arginine deprivation with pegylated prginine deiminase in patients with argininosuccinate synthetase 1-deficient malignant pleu-ral mesothelioma: a randomized clinical trial.","journal-title":"JAMA Oncol"},{"key":"ref=119","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1517\/13543784.2014.934808","volume":"23","author":"Synakiewicz A.","year":"2014","unstructured":"Synakiewicz A, Stachowicz-Stencel T, Adamkiewicz-Drozynska E. The role of arginine and the modified arginine deiminase enzyme ADI-PEG 20 in cancer therapy with special emphasis on Phase I\/II clinical trials.","journal-title":"Expert Opin Investig Drugs"},{"key":"ref=120","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00253-010-3051-z","volume":"90","author":"Ni Y.","year":"2011","unstructured":"Ni Y, Liu Y, Schwaneberg U, Zhu L, Li N, Li L, Sun Z. Rapid evolution of arginine deiminase for improved anti-tumor activity.","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref=121","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0168-3659(02)00042-1","volume":"80","author":"Holtsberg F.W.","year":"2002","unstructured":"Holtsberg FW, Ensor CM, Steiner MR, Bomalaski JS, Clark MA. Poly(ethylene glycol) (PEG) conjugated arginine deiminase: effects of PEG formulations on its pharmacological properties.","journal-title":"J Control Release"},{"key":"ref=122","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10637-012-9807-9","volume":"31","author":"Yau T.","year":"2013","unstructured":"Yau T, Cheng PN, Chan P, Chan W, Chen L, Yuen J, Pang R, Fan ST, Poon RT. A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinoma.","journal-title":"Invest New Drugs"},{"key":"ref=123","doi-asserted-by":"crossref","first-page":"372","DOI":"10.18097\/pbmc20125804372","volume":"58","author":"Lukasheva E.V.","year":"2012","unstructured":"Lukasheva EV. efremova, A.A.; Treshchalina, E.M.; Arinbasarova, A.Iu.; Medentsev, A.G.; Berezov, T.T. [Lamino acid oxidases: properties and molecular mechanisms of action]","journal-title":"Biomed Khim"},{"key":"ref=124","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1023\/A:1006906505745","volume":"197","author":"Murthy S.N.","year":"1999","unstructured":"Murthy SN, Janardanasarma MK. Identification of L-amino acid\/L-lysine alpha-amino oxidase in mouse brain.","journal-title":"Mol Cell Biochem"},{"key":"ref=125","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/S0021-9258(18)96668-8","volume":"241","author":"Nakano M.","year":"1966","unstructured":"Nakano M, Danowski TS. Crystalline mammalian L-amino acid oxidase from rat kidney mitochondria.","journal-title":"J Biol Chem"},{"key":"ref=126","first-page":"53P","volume":"104","author":"Shinwari M.A.","year":"1967","unstructured":"Shinwari MA, Falconer IR. Naturally occurring inhibition and activation of avian liver L-amino acid oxidase.","journal-title":"Biochem J"},{"key":"ref=127","doi-asserted-by":"crossref","first-page":"19080","DOI":"10.1074\/jbc.M200936200","volume":"277","author":"Sun Y.","year":"2002","unstructured":"Sun Y, Nonobe E, Kobayashi Y, Kuraishi T, Aoki F, Yamamoto K, Sakai S. Characterization and expression of L-amino acid oxidase of mouse milk.","journal-title":"J Biol Chem"},{"key":"ref=128","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1172\/JCI106690","volume":"50","author":"Eckstein M.R.","year":"1971","unstructured":"Eckstein MR, Baehner RL, Nathan DG. Amino acid oxidase of leukocytes in relation to H 2 O 2 -mediated bacterial killing.","journal-title":"J Clin Invest"},{"key":"ref=129","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1182\/blood-2006-07-036210","volume":"110","author":"Boulland M.L.","year":"2007","unstructured":"Boulland ML, Marquet J, Molinier-Frenkel V, M\u00f6ller P, Guiter C, Lasoudris F, Copie-Bergman C, Baia M, Gaulard P, Leroy K, Castellano F. Human IL4I1 is a secreted L-phenylalanine oxidase expressed by mature dendritic cells that inhibits T-lymphocyte proliferation.","journal-title":"Blood"},{"key":"ref=130","doi-asserted-by":"crossref","first-page":"4561","DOI":"10.4049\/jimmunol.173.7.4561","volume":"173","author":"Mason J.M.","year":"2004","unstructured":"Mason JM, Naidu MD, Barcia M, Porti D, Chavan SS, Chu CC. IL-4-induced gene-1 is a leukocyte L-amino acid oxidase with an unusual acidic pH preference and lysosomal localization.","journal-title":"J Immunol"},{"key":"ref=131","first-page":"105","volume":"3","author":"Hegde M.","year":"2015","unstructured":"Hegde M, Rao P, Chianeh YR, Fernandes DJ, Shetty J. Serum levels of L-amino acid oxidase in ovarian cancer patients.","journal-title":"Br Biomed Bull"},{"key":"ref=132","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0021-9258(19)86128-8","volume":"255","author":"Kusakabe H.","year":"1980","unstructured":"Kusakabe H, Kodama K, Kuninaka A, Yoshino H, Misono H, Soda K. A new antitumor enzyme, L-lysine alpha-oxidase from . Purification and enzymological properties.","journal-title":"J Biol Chem"},{"key":"ref=133","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.cbpa.2008.07.007","volume":"151","author":"Alves R.M.","year":"2008","unstructured":"Alves RM, Antonucci GA, Paiva HH, Cintra AC, Franco JJ, Mendon\u00e7a-Franqueiro EP, Dorta DJ, Giglio JR, Rosa JC, Fuly AL, Dias-Baruffi M, Soares AM, Sampaio SV. Evidence of caspase-mediated apoptosis induced by l-amino acid oxidase isolated from snake venom.","journal-title":"Comp Biochem Physiol A Mol Integr Physiol"},{"key":"ref=134","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/bcpt.12155","volume":"114","author":"Lee L.M.","year":"2014","unstructured":"Lee LM, Chung I, Yee Fung S, Kanthimathi MS, Hong Tan N. Antiproliferative activity of king cobra () venom L-amino acid oxidase.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"ref=135","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1046\/j.1432-1327.2001.02321.x","volume":"268","author":"Geyer A.","year":"2001","unstructured":"Geyer A, Fitzpatrick TB, Pawelek PD, Kitzing K, Vrielink A, Ghisla S, Macheroux P. Structure and characterization of the glycan moiety of L-amino-acid oxidase from the Malayan pit viper","journal-title":"Eur J Biochem"},{"key":"ref=136","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jmb.2006.09.032","volume":"364","author":"Moustafa I.M.","year":"2006","unstructured":"Moustafa IM, Foster S, Lyubimov AY, Vrielink A. Crystal structure of LAAO from with an L-phenylalanine substrate: Insights into structure and mechanism.","journal-title":"J Mol Biol"},{"key":"ref=137","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s10495-006-7959-9","volume":"11","author":"Ande S.R.","year":"2006","unstructured":"Ande SR, Kommoju PR, Draxl S, Murkovic M, Macheroux P, Ghisla S, Ferrando-May E. Mechanisms of cell death induction by L-amino acid oxidase, a major component of ophidian venom.","journal-title":"Apoptosis"},{"key":"ref=138","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1678-9199-20-23","volume":"20","author":"Costa T.R.","year":"2014","unstructured":"Costa TR, Burin SM, Menaldo DL, de Castro FA, Sampaio SV. Snake venom L-amino acid oxidases: An overview on their antitumor effects.","journal-title":"J Venom Anim Toxins Incl Trop Dis"},{"key":"ref=139","doi-asserted-by":"crossref","first-page":"7034","DOI":"10.1016\/j.bmc.2006.06.025","volume":"14","author":"Izidoro L.F.","year":"2006","unstructured":"Izidoro LF, Ribeiro MC, Souza GR, Sant\u2019Ana CD, Hamaguchi A, Homsi-Brandeburgo MI, Goulart LR, Beleboni RO, Nomizo A, Sampaio SV, Soares AM, Rodrigues VM. Biochemical and functional characterization of an L-amino acid oxidase isolated from snake venom.","journal-title":"Bioorg Med Chem"},{"key":"ref=140","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.bbrc.2003.08.044","volume":"309","author":"Zhang Y.J.","year":"2003","unstructured":"Zhang YJ, Wang JH, Lee WH, Wang Q, Liu H, Zheng YT, Zhang Y. Molecular characterization of venom L-amino acid oxidase with potential anti-HIV activity.","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=141","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1006\/abbi.1999.1287","volume":"368","author":"Souza D.H.","year":"1999","unstructured":"Souza DH, Eugenio LM, Fletcher JE, Jiang MS, Garratt RC, Oliva G, Selistre-de-Araujo HS. Isolation and structural characterization of a cytotoxic L-amino acid oxidase from snake venom: Preliminary crystallographic data.","journal-title":"Arch Biochem Biophys"},{"key":"ref=142","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.bbapap.2006.01.021","volume":"1764","author":"Samel M.","year":"2006","unstructured":"Samel M, Vija H, R\u00f6nnholm G, Siigur J, Kalkkinen N, Siigur E. Isolation and characterization of an apoptotic and platelet aggregation inhibiting L-amino acid oxidase from (common viper) venom.","journal-title":"Biochim Biophys Acta"},{"key":"ref=143","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0887-2333(03)00010-9","volume":"17","author":"Sun L.K.","year":"2003","unstructured":"Sun LK, Yoshii Y, Hyodo A, Tsurushima H, Saito A, Harakuni T, Li YP, Kariya K, Nozaki M, Morine N. Apoptotic effect in the glioma cells induced by specific protein extracted from Okinawa Habu () venom in relation to oxidative stress.","journal-title":"Toxicol In Vitro"},{"key":"ref=144","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1093\/emboj\/19.16.4204","volume":"19","author":"Pawelek P.D.","year":"2000","unstructured":"Pawelek PD, Cheah J, Coulombe R, Macheroux P, Ghisla S, Vrielink A. The structure of L-amino acid oxidase reveals the substrate trajectory into an enantiomerically conserved active site.","journal-title":"EMBO J"},{"key":"ref=145","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0145-305X(02)00140-4","volume":"27","author":"Iijima R.","year":"2003","unstructured":"Iijima R, Kisugi J, Yamazaki M. L-amino acid oxidase activity of an antineoplastic factor of a marine mollusk and its relationship to cytotoxicity.","journal-title":"Dev Comp Immunol"},{"key":"ref=146","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.bbagen.2011.04.003","volume":"1810","author":"Naumann G.B.","year":"2011","unstructured":"Naumann GB, Silva LF, Silva L, Faria G, Richardson M, Evangelista K, Kohlhoff M, Gontijo CM, Navdaev A, de Rezende FF, Eble JA, Sanchez EF. Cytotoxicity and inhibition of platelet aggregation caused by an l-amino acid oxidase from venom.","journal-title":"Biochim Biophys Acta"},{"key":"ref=147","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.toxicon.2012.08.008","volume":"60","author":"Bregge-Silva C.","year":"2012","unstructured":"Bregge-Silva C, Nonato MC, de Albuquerque S, Ho PL, Junqueira de Azevedo IL, Vasconcelos Diniz MR, Lomonte B, Rucavado A, D\u00edaz C, Guti\u00e9rrez JM, Arantes EC. Isolation and biochemical, functional and structural characterization of a novel L-amino acid oxidase from snake venom.","journal-title":"Toxicon"},{"key":"ref=148","first-page":"163","volume":"53","author":"Smirnova I.P.","year":"1984","unstructured":"Smirnova IP, Khaduev SKh. [L-lysine-alpha-oxidase activity of some Trichoderma species].","journal-title":"Mikrobiologiia"},{"key":"ref=149","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/jb\/mvv012","volume":"157","author":"Amano M.","year":"2015","unstructured":"Amano M, Mizuguchi H, Sano T, Kondo H, Shinyashiki K, Inagaki J, Tamura T, Kawaguchi T, Kusakabe H, Imada K, Inagaki K. Recombinant expression, molecular characterization and crystal structure of antitumor enzyme, L-lysine \u03b1-oxidase from","journal-title":"J Biochem"},{"key":"ref=150","doi-asserted-by":"crossref","first-page":"99","DOI":"10.18097\/pbmc20156101099","volume":"61","author":"Lukasheva E.V.","year":"2014","unstructured":"Lukasheva EV, Ribakova JS, Fedorova TN, Makletsova MG, Arinbasarova AY, Medentzev AGTT. B.; [Effect of L-lysine alpha-oxidase from Trichoderma cf. aureoviride Rifai \u0412\u041a\u041cF-4268D on pheochromocytoma PC12 cell line]","journal-title":"Biomed Khim"},{"key":"ref=151","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1385\/ABAB:88:1-3:267","volume":"88","author":"Treshalina H.M.","year":"2000","unstructured":"Treshalina HM, Lukasheva EV, Sedakova LA, Firsova GA, Guerassimova GK, Gogichaeva NV, Be-rezov TT. Anticancer enzyme L-lysine \u03b1-oxidase.","journal-title":"Appl Biochem Biotechnol"},{"key":"ref=152","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/CAD.0b013e328362fbe2","volume":"24","author":"Pokrovsky V.S.","year":"2013","unstructured":"Pokrovsky VS, Treshalina HM, Lukasheva EV, Sedakova LA, Medentzev AG, Arinbasarova AY, Berezov TT. Enzymatic properties and anticancer activity of L-lysine \u03b1-oxidase from . aureoviride Rifai BKMF-4268D.","journal-title":"Anticancer Drugs"},{"key":"ref=153","first-page":"410","volume":"46","author":"Gogichaeva N.V.","year":"2000","unstructured":"Gogichaeva NV, Lukasheva EV, Gavrilova EM, Smirnova IP, Egorov AM, Berezov TT. [Synthesis of conjugates of L-lysine alpha-oxidase with antibodies].","journal-title":"Vopr Med Khim"},{"key":"ref=154","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1023\/A:1020967408229","volume":"67","author":"Lukasheva E.V.","year":"2002","unstructured":"Lukasheva EV, Berezov TT. L-Lysine alpha-oxidase: Physicochemical and biological properties.","journal-title":"Biochemistry (Mosc)"},{"key":"ref=155","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00253-009-2303-2","volume":"86","author":"El-Sayed A.S.","year":"2010","unstructured":"El-Sayed AS. Microbial L-methioninase: Production, molecular characterization, and therapeutic applications.","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref=156","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s12275-011-0259-2","volume":"49","author":"El-Sayed A.S.","year":"2011","unstructured":"El-Sayed AS. Purification and characterization of a new L-methioninase from solid cultures of Aspergillus flavipes.","journal-title":"J Microbiol"},{"key":"ref=157","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.ctrv.2012.01.004","volume":"38","author":"Cavuoto P.","year":"2012","unstructured":"Cavuoto P, Fenech MF. A review of methionine dependency and the role of methionine restriction in cancer growth control and life-span extension.","journal-title":"Cancer Treat Rev"},{"key":"ref=158","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0305-7372(03)00118-X","volume":"29","author":"Cellarier E.","year":"2003","unstructured":"Cellarier E, Durando X, Vasson MP, Farges MC, Demiden A, Maurizis JC, Madelmont JC, Chollet P. Methionine dependency and cancer treatment.","journal-title":"Cancer Treat Rev"},{"key":"ref=159","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1134\/S0006297906040031","volume":"71","author":"Manukhov I.V.","year":"2006","unstructured":"Manukhov IV, Mamaeva DV, Morozova EA, Rastorguev SM, Faleev NG, Demidkina TV, Zavilgelsky GB. L-methionine gamma-lyase from : Cloning of the gene and kinetic parameters of the enzyme.","journal-title":"Biochemistry (Mosc)"},{"key":"ref=160","first-page":"1041","volume":"30","author":"Tan Y.","year":"2010","unstructured":"Tan Y, Xu M, Hoffman RM. Broad selective efficacy of recombinant methioninase and polyethylene glycol-modified recombinant methioninase on cancer cells","journal-title":"Anticancer Res"},{"key":"ref=161","doi-asserted-by":"crossref","first-page":"92","DOI":"10.32607\/20758251-2013-5-3-92-98","volume":"5","author":"Morozova E.A.","year":"2013","unstructured":"Morozova EA, Kulikova VV, Yashin DV, Anufrieva NV, Anisimova NY, Revtovich SV, Kotlov MI, Belyi YF, Pokrovsky VS, Demidkina TV. Kinetic parameters and cytotoxic activity of recombinant methionine \u03b3- from and","journal-title":"Acta Naturae"},{"key":"ref=162","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1517\/14712598.2015.963050","volume":"15","author":"Hoffman R.M.","year":"2015","unstructured":"Hoffman RM. Development of recombinant methioninase to target the general cancer-specific metabolic defect of methionine dependence: A 40-year odyssey.","journal-title":"Expert Opin Biol Ther"},{"key":"ref=163","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.biopha.2017.01.127","volume":"88","author":"Morozova E.A.","year":"2017","unstructured":"Morozova EA, Anufrieva NV, Davydov DZ, Komarova MV, Dyakov IN, Rodionov AN, Demidkina TV, Pokrovsky VS. Plasma methionine depletion and pharmacokinetic properties in mice of methionine \u03b3-lyase from and","journal-title":"Biomed Pharmacother"},{"key":"ref=164","first-page":"3515","volume":"16","author":"Hoshiya Y.","year":"1996","unstructured":"Hoshiya Y, Kubota T, Matsuzaki SW, Kitajima M, Hoffman RM. Methionine starvation modulates the efficacy of cisplatin on human breast cancer in nude mice.","journal-title":"Anticancer Res"},{"key":"ref=165","first-page":"2157","volume":"5","author":"Tan Y.","year":"1999","unstructured":"Tan Y, Sun X, Xu M, Tan X, Sasson A, Rashidi B, Han Q, Tan X, Wang X, An Z, Sun FX, Hoffman RM. Efficacy of recombinant methioninase in combination with cisplatin on human colon tumors in nude mice.","journal-title":"Clin Cancer Res"},{"key":"ref=166","first-page":"2583","volume":"58","author":"Yoshioka T.","year":"1998","unstructured":"Yoshioka T, Wada T, Uchida N, Maki H, Yoshida H, Ide N, Kasai H, Hojo K, Shono K, Maekawa R, Yagi S, Hoffman RM, Sugita K. Anticancer efficacy and , synergy with 5-fluorouracil, and safety of recombinant methioninase.","journal-title":"Cancer Res"},{"key":"ref=167","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/ijc.24104","volume":"124","author":"Hu J.","year":"2009","unstructured":"Hu J, Cheung NK. Methionine depletion with recombinant methioninase: and efficacy against neuroblastoma and its synergism with chemotherapeutic drugs.","journal-title":"Int J Cancer"},{"key":"ref=168","first-page":"4017","volume":"61","author":"Kokkinakis D.M.","year":"2001","unstructured":"Kokkinakis DM, Hoffman RM, Frenkel EP, Wick JB, Han Q, Xu M, Tan Y, Schold SC. Synergy between methionine stress and chemotherapy in the treatment of brain tumor xenografts in athymic mice.","journal-title":"Cancer Res"},{"key":"ref=169","first-page":"3937","volume":"16","author":"Tan Y.","year":"1996","unstructured":"Tan Y, Zavala J, Xu M, Zavala J, Hoffman RM. Serum methionine depletion without side effects by methioninase in metastatic breast cancer patients.","journal-title":"Anticancer Res"},{"key":"ref=170","first-page":"8377","volume":"63","author":"Sun X.","year":"2003","unstructured":"Sun X, Yang Z, Li S, Tan Y, Zhang N, Wang X, Yagi S, Yoshioka T, Takimoto A, Mitsushima K, Suginaka A, Frenkel EP, Hoffman RM. In vivo efficacy of recombinant methioninase is enhanced by the combination of polyethylene glycol conjugation and pyridoxal 5\u2032-phosphate supplementation.","journal-title":"Cancer Res"},{"key":"ref=171","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1166\/jnn.2013.6881","volume":"13","author":"Xin L.","year":"2013","unstructured":"Xin L, Cao J, Cheng H, Zeng F, Hu X. Stealth cationic liposomes modified with anti-CAGE single-chain fragment variable deliver recombinant methioninase for gastric carcinoma therapy.","journal-title":"J Nanosci Nanotechnol"},{"key":"ref=172","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1104\/pp.113.1.175","volume":"113","author":"R\u00f6sler J.","year":"1997","unstructured":"R\u00f6sler J, Krekel F, Amrhein N, Schmid J. Maize phenylalanine ammonia-lyase has tyrosine ammonia-lyase activity.","journal-title":"Plant Physiol"},{"key":"ref=173","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0141-0229(96)00013-0","volume":"19","author":"D\u2019Cunha G.B.","year":"1996","unstructured":"D\u2019Cunha GB, Satyanarayan V, Nair PM. Stabilization of phenylalanine ammonia lyase containing Rhodotorula glu-tinis cells for the continuous synthesis of L-phenylalanine methyl ester\/96.","journal-title":"Enzyme Microb Technol"},{"key":"ref=174","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1042\/bj1490065","volume":"149","author":"Kalghatgi K.K.","year":"1975","unstructured":"Kalghatgi KK, Subba Rao PV. Microbial L-phenylalanine ammonia-lyase. Purification, subunit structure and kinetic properties of the enzyme from","journal-title":"Biochem J"},{"key":"ref=175","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0031-9422(96)00282-8","volume":"43","author":"Kim S.H.","year":"1996","unstructured":"Kim SH, Kronstad JW, Ellis BE. Purification and characterization of phenylalanine ammonia-lyase from Ustilago maydis.","journal-title":"Phytochemistry"},{"key":"ref=176","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1021\/bi061774g","volume":"46","author":"Moffitt M.C.","year":"2007","unstructured":"Moffitt MC, Louie GV, Bowman ME, Pence J, Noel JP, Moore BS. Discovery of two cyanobacterial phenylalanine ammonia lyases: Kinetic and structural characterization.","journal-title":"Biochemistry"},{"key":"ref=177","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.phytochem.2010.09.019","volume":"71","author":"Hsieh L.S.","year":"2010","unstructured":"Hsieh LS, Ma GJ, Yang CC, Lee PD. Cloning, expression, site-directed mutagenesis and immunolo-calization of phenylalanine ammonia-lyase in","journal-title":"Phytochemistry"},{"key":"ref=178","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1016\/S0021-9258(19)61721-7","volume":"236","author":"Koukol J.","year":"1961","unstructured":"Koukol J, Conn EE. The metabolism of aromatic com-pounds in higher plants. IV. Purification and properties of the phenylalanine deaminase of","journal-title":"J Biol Chem"},{"key":"ref=179","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1016\/S0021-9258(17)33251-9","volume":"251","author":"Fritz R.R.","year":"1976","unstructured":"Fritz RR, Hodgins DS, Abell CW. Phenylalanine ammonia-lyase. Induction and purification from yeast and clearance in mammals.","journal-title":"J Biol Chem"},{"key":"ref=180","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/0031-9422(73)85001-0","volume":"12","author":"Camm E.L.","year":"1973","unstructured":"Camm EL, Towers GN. Phenylalanine ammonia lyase.","journal-title":"Phytochemistry"},{"key":"ref=181","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/BF01198755","volume":"8","author":"Kawasaki Watanabe S.","year":"1992","unstructured":"Kawasaki Watanabe S, Hernandez-Velazco G, Iturbe-Chi\u00f1as F, Lopez-Munguia A. Phenylalanine ammonia lyase from and Application for phenylalanine and tyrosine deamination.","journal-title":"World J Microbiol Biotechnol"},{"key":"ref=182","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1139\/o70-099","volume":"48","author":"Emes A.V.","year":"1970","unstructured":"Emes AV, Vining LC. Partial purification and properties of L-phenylalanine ammonia-lyase from","journal-title":"Can J Biochem"},{"key":"ref=183","volume":"2","author":"Pridham J.B.","year":"1974","unstructured":"Pridham JB, Woodhead S. Multimolecular forms of phenylalanine-ammonia lyase in Alternaria."},{"key":"ref=184","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02783735","volume":"10","author":"Bourget L.","year":"1984","unstructured":"Bourget L, Chang TM. Artificial cell-microencapsulated phenylalanine ammonia-lyase.","journal-title":"Appl Biochem Biotechnol"},{"key":"ref=185","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.ymgme.2005.06.016","volume":"86","author":"Sarkissian C.N.","year":"2005","unstructured":"Sarkissian CN, G\u00e1mez A. Phenylalanine ammonia lyase, enzyme substitution therapy for phenylketonuria, where are we now?","journal-title":"Mol Genet Metab"},{"key":"ref=186","first-page":"2529","volume":"33","author":"Abell C.W.","year":"1973","unstructured":"Abell CW, Hodgins DS, Stith WJ. An evaluation of the chemotherapeutic potency of phenylalanine ammonia-lyase.","journal-title":"Cancer Res"},{"key":"ref=187","first-page":"966","volume":"33","author":"Stith W.J.","year":"1973","unstructured":"Stith WJ, Hodgins DS, Abell CW. Effects of phenylalanine amonia-lyase and phenylalanine deprivation on murine leukemic lymphoblasts","journal-title":"Cancer Res"},{"key":"ref=188","doi-asserted-by":"crossref","first-page":"531","DOI":"10.7326\/0003-4819-106-4-531","volume":"106","author":"Ambrus C.M.","year":"1987","unstructured":"Ambrus CM, Anthone S, Horvath C, Kalghatgi K, Lele AS, Eapen G, Ambrus JL, Ryan AJ, Li P. Extracorporeal enzyme reactors for depletion of phenylalanine in phenylketonuria.","journal-title":"Ann Intern Med"},{"key":"ref=189","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/bab.1089","volume":"60","author":"Babich O.O.","year":"2013","unstructured":"Babich OO, Pokrovsky VS, Anisimova NY, Sokolov NN, Prosekov AY. Recombinant l-phenylalanine ammonia lyase from as a potential anticancer agent.","journal-title":"Biotechnol Appl Biochem"},{"key":"ref=190","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0065-2164(08)70431-3","volume":"19","author":"Yamada H.","year":"1975","unstructured":"Yamada H, Kumagai H. Synthesis of L-tyrosine-related amino acids by beta-tyrosinase.","journal-title":"Adv Appl Microbiol"},{"key":"ref=191","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0014-5793(88)80774-9","volume":"232","author":"Demidkina T.V.","year":"1988","unstructured":"Demidkina TV, Myagkikh IV, Antson AA, Harutyunyan EH. Crystallization and crystal data on tyrosine phenol-lyase.","journal-title":"FEBS Lett"},{"key":"ref=192","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0305-0491(77)90029-3","volume":"56","author":"Duffey S.S.","year":"1977","unstructured":"Duffey SS, Aldrich JR, Blum MS. Biosynthesis of phenol and guaiacol by the hemipteran","journal-title":"Comp Biochem Physiol B"},{"key":"ref=193","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1080\/00021369.1972.10860505","volume":"36","author":"Enei H.","year":"1972","unstructured":"Enei H, Matsui H, Yamashita H, Okumura S, Yamada H. Distribution of tyrosine phenol-lyase in microorganisms.","journal-title":"Agric Biol Chem"},{"key":"ref=194","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0141-0229(96)00001-4","volume":"19","author":"Lee S-G.","year":"1996","unstructured":"Lee S-G, Hong S-P, Sung M-H. Removal and biocon-version of phenol in wastewater by a thermostable \u03b2-tyrosinase.","journal-title":"Enzyme Microb Technol"},{"key":"ref=195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00253-005-0155-y","volume":"69","author":"Leuchtenberger W.","year":"2005","unstructured":"Leuchtenberger W, Huthmacher K, Drauz K. Biotechnological production of amino acids and derivatives: Current status and prospects.","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref=196","first-page":"167","volume":"36","author":"Meadows G.G.","year":"1976","unstructured":"Meadows GG, DiGiovanni J, Minor L, Elmer GW. Some biological properties and an evaluation of tyrosine phenol-lyase on growth of B-16 melanoma.","journal-title":"Cancer Res"},{"key":"ref=197","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4143\/crt.2013.45.4.251","volume":"45","author":"Phillips M.M.","year":"2013","unstructured":"Phillips MM, Sheaff MT, Szlosarek PW. Targeting arginine-dependent cancers with arginine-degrading enzymes: Opportunities and challenges.","journal-title":"Cancer Res Treat"},{"key":"ref=198","first-page":"42","volume":"7","author":"Zhukova O.S.","year":"1985","unstructured":"Zhukova OS, Khaduev SKh, Dobrynin IaV, Smirnova MP, Lukasheva EV. [Effect of L-lysine-alpha-oxidase on the cell cycle kinetics of cultured Burkitt\u2019s lymphoma cells]","journal-title":"Eksp Onkol"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/156250","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T16:56:24Z","timestamp":1719507384000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/156250\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,26]]},"references-count":198,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3,26]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867324666171006132729","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3,26]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2017-02-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-09-12","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-09-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}